The 48 rating InvestorsObserver gives to NovaBay Pharmaceuticals, Inc. (NBY) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 43 percent of stocks in the Biotechnology industry, NBY’s 48 overall rating means the stock scores better than 48 percent of all stocks.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 48 means the stock is more attractive than 48 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With NovaBay Pharmaceuticals, Inc. Stock Today?
NovaBay Pharmaceuticals, Inc. (NBY) stock is lower by -11.28% while the S&P 500 is flat 0% as of 12:22 PM on Friday, Aug 7. NBY is lower by -$0.14 from the previous closing price of $1.29 on volume of 2,667,265 shares. Over the past year the S&P 500 has gained 13.99% while NBY is lower by -0.87%. NBY lost -$0.33 per share the over the last 12 months.
To see InvestorsObserver's Sentiment Score for NovaBay Pharmaceuticals, Inc. click here.
